Predicting outcome in peritoneal dialysis-related peritonitis: Revisiting old themes and slowly moving forward

Peritoneal Dialysis International

Volumn 28, Issue 4, 2008, Pages 335-339

  Zalunardo, Nadia ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; RECEPTOR INTERACTING PROTEIN 2; RECEPTOR PROTEIN;

AGE; ASCITES; BACTERIAL PERITONITIS; CARDIOVASCULAR DISEASE; CATHETER REMOVAL; CD4 CD8 RATIO; CELLULAR IMMUNITY; COMORBIDITY; CYTOKINE PRODUCTION; DIABETES MELLITUS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; MORBIDITY; MORTALITY; MYCOSIS; NOTE; NUTRITIONAL STATUS; PARACENTESIS; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCLEROSING PERITONITIS; SEX DIFFERENCE; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 48749101720     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800404     Document Type: Note

References (33)

1. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; 103:S55-62.
2. Troidle L, Gorban-Brennan N, Finkelstein FO. Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis. Adv Perit Dial 2005; 21:98-101.
3. Szeto CC, Chow KM, Wong TY, Leung CB, Wang AY, Lui SF, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal J Am Soc Nephrol 2002; 13:1040-5.
4. Cox SD, Walsh SB, Yaqoob MM, Fan S. Predictors of survival and technique success after reinsertion of peritoneal dialysis catheter following severe peritonitis. Perit Dial Int 2007; 27:67-73.
5. Lui SL, Chan TM, Lai KN, Lo WK. Tuberculous and fungal peritonitis in patients undergoing ambulatory peritoneal dialysis. Perit Dial Int 2007; 27(Suppl 2):S263-6.
6. Szeto CC, Chow KM. Gram-negative peritonitis - the Achilles heel of peritoneal dialysis? Perit Dial Int 2007; 27(Suppl 2):S267-71.
7. Choi P, Nemati E, Banerjee A, Preston E, Levy J, Brown E. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 2004; 43:103-11.
8. Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 2000; 36:1000-8.
9. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
10. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. The clinical course of culture-negative peritonitis complicating peritoneal dialysis. Am J Kidney Dis 2003; 42:567-74.
11. Murata GH, Fox L, Tzamaloukas AH. Predicting the course of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. Arch Intern Med 1993; 153:2317-21.
12. Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22:573-81.
13. Chow KM, Szeto CC, Cheung KK, Leung CB, Wong SS, Law MC, et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal. dialysis. Clin J Am Soc Nephrol 2006; 1:768-73.
14. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274-84.
15. Digenis GE, Abraham G, Savin E, Blake P, Dombros N, Sombolos K, et al. Peritonitis-related deaths in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1990; 10:45-7.
16. Shah GM, Sabo A, Winer RL, Ross EA, Kirschenbaum MA. Peritoneal leucocyte response to bacterial peritonitis in patients receiving peritoneal dialysis. Int J Artif Organs 1990; 13:44-50.
17. Wang HH, Lin CY. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the type I/type II T-cell immune response. Am J Kidney Dis 2005; 46:328-38.
18. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005; 117:104-11.
19. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351:2599-610.
20. Lacson E, Levin NW. C-reactive protein and end-stage renal disease. Semin Dial 2004; 17:438-48.
21. Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005; 68:766-72.
22. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290:353-9.
23. Kim SB, Min WK, Lee SK, Park JS, Hong CD, Yang WS. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2002; 39:342-6.
24. Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15:2186-94.
25. Troidle L, Kliger A, Gorban-Brennan N, Finkelstein F. Course of C-reactive protein during continuous peritoneal dialysis-associated peritonitis. Nephrology 2005; 10: 442-5.
26. Zalunardo NY, Rose CL, Ma IW, Altmann P. Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis. Kidney Int 2007; 71:687-92.
27. Wang HH, Lin CY, Huang TP. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2003; 18:1181-9.
28. McCully ML, Baroja ML, Chau TA, Jain AK, Barra L, Salgado A, et al. Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis. Kidney Int 2007; 72:1273-81.
29. Moon SJ, Han SH, Kim DK, Lee JE, Kim BS, Kang SW, et al. Risk factors for adverse outcomes after peritonitis-related technique failure. Perit Dial Int 2008; 28:352-60.
30. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68: 2381-8.
31. Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int 2005; 25(Suppl 4):S14-18.
32. Ates K, Ates A, Ekmekci Y, Nergizoglu G. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int 2005; 25:256-68.
33. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied Regression Analysis and Other Multivariable Methods. 3rd ed. Pacific Grove, CA: Brooks/Cole; 1998.